On 19 May 2017
Glaxosmithkline Pharma will hold a meeting of the Board of Directors of the Company on 19 May 2017 the approval and declaration of Audited Financial Results for the year and quarter ended 31st March, 2017.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)